Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive & Nonradioactive

Comparison study on radiolabeling antibodies with 89Zr produced from solid and liquid target systems

Gemma Dias, Elisabeth Oehlke, Cornelia Hoehr, Paul Schaffer, Kuo-Shyan Lin, Ken Buckley and Francois Benard
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 609;
Gemma Dias
1Molecular Oncology, BC Cancer Agency, Vancouver, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisabeth Oehlke
2TRIUMF, Vancouver, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cornelia Hoehr
2TRIUMF, Vancouver, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Schaffer
2TRIUMF, Vancouver, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kuo-Shyan Lin
1Molecular Oncology, BC Cancer Agency, Vancouver, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken Buckley
2TRIUMF, Vancouver, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francois Benard
1Molecular Oncology, BC Cancer Agency, Vancouver, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

609

Objectives Zirconium-89 (89Zr) is an attractive radioisotope for radiolabeling of monoclonal antibodies (mAb). Our group has produced 89Zr using both solid and salt-solution (liquid) yttrium (Y) targets. The aim of this study was to assess and compare antibody radiolabeling yields between 89Zr produced from different target systems.

Methods Two solid target (ST) 89Y discs, each 10 mm diameter with 99.9% purity but different thicknesses (disc 1 (ST1): 1.016 mm 0.356 g and disc 2 (ST2) 0.254 mm, 0.087 g) were bombarded with 13.9 MeV protons for 40 min (800 μA.min). The liquid target (LT) material consisted of 2.75M natY(NO3)3 in nitric acid (1M) with a yttrium purity of 99.9% and density of 1.49 g/mL, were bombarded for 60 min with 13 MeV protons (426 μA.min). Dissolved ST discs and the LT solution were adjusted to 2M with HCl and purified by the same batch of hydroxamate resin. Zr chelator, deferoxamine (Df) was conjugated to mAb (3:1 ratio) and purified by centrifugation. Antibody labeling was performed in HEPES buffer (0.5 M, pH 7.1) at room temperature overnight with a mAb-Df concentration of 0.9 mg/mL (ST1 and ST2) or 0.3 mg/mL (LT). Radiolabeling yields were determined after PD-10 column purification.

Results End of bombardment yields for 89Zr were 696 MBq (ST1), 420 MBq (ST2) and 13.6 MBq (LT). 89Zr eluted from the hydroxamate resin using 3x0.5mL 1M oxalic acid with 453 MBq (ST1), 385 MBq (ST2) and 10.4 MBq (LT) respectively eluting within the first 0.5 mL. Radiolabeling of mAb-Df used 7.2 MBq, 20uL (ST1), 6.7 MBq, 20uL (ST2) and 7.8 MBq, 0.5mL (LT) of 89Zr-oxalate with yields of 80% (ST1), 79% (ST2) and 68% (LT).

Conclusions Successful mAb labeling was achieved with 899Zr produced from all target systems. Slightly lower radiolabeling yield from 89Zr produced by liquid target might be due to dilution of mAb-Df in the LT reaction caused by a lower 89Zr-oxalate concentration.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 55, Issue supplement 1
May 2014
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comparison study on radiolabeling antibodies with 89Zr produced from solid and liquid target systems
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Comparison study on radiolabeling antibodies with 89Zr produced from solid and liquid target systems
Gemma Dias, Elisabeth Oehlke, Cornelia Hoehr, Paul Schaffer, Kuo-Shyan Lin, Ken Buckley, Francois Benard
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 609;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Comparison study on radiolabeling antibodies with 89Zr produced from solid and liquid target systems
Gemma Dias, Elisabeth Oehlke, Cornelia Hoehr, Paul Schaffer, Kuo-Shyan Lin, Ken Buckley, Francois Benard
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 609;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive & Nonradioactive

  • In vitro response of 177Lu-PSMA-617 with two different specific activities
  • Synthesis and preclinical evaluation of 11C-labeled (6-aryl-1H-pyrrolo[3,2-b]pyridin-1-yl)acetamide for imaging GluN2B subunit of NMDA receptors
  • Synthesis and Preliminary Evaluation of Metabolically Stable 18F-Lableled PET Tracer for Fatty Acid Beta-Oxidation Imaging.
Show more Molecular Targeting Probes - Radioactive & Nonradioactive

Radiopharmacy

  • Radiochemical Purity of Common On-Call Kits Utilizing Tc-99m Eluate Near Its Beyond Use Date
  • Large Anterior Mediastinum Mass Activity on 99mTc-Tetrofosmin Myocardial Perfusion Imaging
  • The Inconsistencies of Iodine Capsule Dosimetry and Calibration
Show more Radiopharmacy

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire